A Potential Role for PTEN in the Diabetic Heart
- 16 June 2006
- journal article
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 20 (4) , 319-321
- https://doi.org/10.1007/s10557-006-8876-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Increased PTEN expression due to transcriptional activation of PPARγ by Lovastatin and RosiglitazoneInternational Journal of Cancer, 2006
- PTEN Activity Is Modulated During Ischemia and ReperfusionCirculation Research, 2005
- Phosphatase and Tensin Homolog Regulation of Islet Growth and Glucose HomeostasisJournal of Biological Chemistry, 2005
- Preconditioning the Diabetic HeartDiabetes, 2005
- Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatmentJournal of the American College of Cardiology, 2005
- Altered Insulin Signaling in Retinal Tissue in Diabetic StatesJournal of Biological Chemistry, 2004
- The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and diseaseJournal of Molecular and Cellular Cardiology, 2004
- New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathwayCardiovascular Research, 2004
- THE MECHANISM OF ACTION OF THE TUMOUR SUPPRESSOR GENE PTENBiomedical Papers, 2003
- Specific Inhibition of PTEN Expression Reverses Hyperglycemia in Diabetic MiceDiabetes, 2002